Insmed Inc Stock Price on October 31, 2024
| INSM Stock | USD 74.09 0.94 1.29% |
Below is the normalized historical share price chart for Insmed Inc extending back to June 01, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Insmed stands at 74.09, as last reported on the 26th of November, with the highest price reaching 76.46 and the lowest price hitting 74.05 during the day.
If you're considering investing in Insmed Stock, it is important to understand the factors that can impact its price. Insmed Inc holds Efficiency (Sharpe) Ratio of -0.008, which attests that the entity had a -0.008% return per unit of risk over the last 3 months. Insmed Inc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Insmed's Standard Deviation of 2.55, risk adjusted performance of (0.02), and Market Risk Adjusted Performance of (0.05) to validate the risk estimate we provide.
At this time, Insmed's Common Stock Shares Outstanding is very stable compared to the past year. As of the 26th of November 2024, Liabilities And Stockholders Equity is likely to grow to about 1.4 B, while Common Stock Total Equity is likely to drop about 804.3 K. . As of the 26th of November 2024, Price To Sales Ratio is likely to drop to 13.55. In addition to that, Price Earnings Ratio is likely to drop to -6.1. Insmed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 1st of June 2000 | 200 Day MA 54.5014 | 50 Day MA 72.0374 | Beta 1.12 |
Insmed |
Sharpe Ratio = -0.008
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | INSM |
Estimated Market Risk
| 2.53 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Insmed is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Insmed by adding Insmed to a well-diversified portfolio.
Price Book 27.0714 | Enterprise Value Ebitda (6.05) | Price Sales 38.1585 | Shares Float 167.6 M | Wall Street Target Price 89.3982 |
Related Headline
Blueprint Medicines Headline on 31st of October 2024
Blueprint Medicines Given New 151.00 Price Target at Wells F... by thelincolnianonline.com
Blueprint Medicines had its price target dropped by research analysts at Wells Fargo Company from 153.00 to 151.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has an overweight rating on the biotechnology companys stock. Wells Fargo Companys price objective indicates a
Insmed Valuation on October 31, 2024
It is possible to determine the worth of Insmed on a given historical date. On October 31, 2024 Insmed was worth 68.59 at the beginning of the trading date compared to the closed value of 67.28. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Insmed stock. Still, in general, we apply an absolute valuation method to find Insmed's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Insmed where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Insmed's related companies.
| Open | High | Low | Close | Volume | |
| 70.65 | 71.37 | 70.00 | 70.30 | 1,170,124 | |
10/31/2024 | 68.59 | 70.39 | 67.05 | 67.28 | 2,431,099 |
| 67.78 | 68.88 | 65.95 | 68.32 | 1,617,227 |
| Backtest Insmed | | | Insmed History | | | Insmed Valuation | Previous | Next |
Insmed Trading Date Momentum on October 31, 2024
| On November 01 2024 Insmed Inc was traded for 68.32 at the closing time. The top price for the day was 68.88 and the lowest listed price was 65.95 . The trading volume for the day was 1.6 M. The trading history from November 1, 2024 was a factor to the next trading day price boost. The trading delta at closing time against the next closing price was 1.55% . The trading delta at closing time against the current closing price is 9.32% . |
Insmed Inc Fundamentals Correlations and Trends
By evaluating Insmed's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Insmed's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Insmed financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Insmed Stock history
Insmed investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Insmed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Insmed Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Insmed stock prices may prove useful in developing a viable investing in Insmed
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 140.4 M | 147.5 M | |
| Net Loss | -433.4 M | -411.7 M |
Insmed Quarterly Net Working Capital |
|
Insmed Stock Technical Analysis
Insmed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Insmed Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Insmed Inc cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Insmed November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Insmed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Insmed shares will generate the highest return on investment. By undertsting and applying Insmed stock market strength indicators, traders can identify Insmed Inc entry and exit signals to maximize returns
Insmed Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Insmed's price direction in advance. Along with the technical and fundamental analysis of Insmed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Insmed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.06) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.55) | Revenue Per Share 2.206 | Quarterly Revenue Growth 0.182 | Return On Assets (0.26) | Return On Equity (8.91) |
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.